Yuyu Pharma

CompanySouth KoreaFounded 1941

Yuyu Pharma develops one asset, in phase 1 (Maxmarvil in osteoporosis). Mostly small molecule acting on VDR and FDPS; based in South Korea, founded in 1941.

1
Asset
Furthest stage: Phase 1; 1
Trial: 0
Signals

Pipeline

1

Maxmarvil
Combination of alendronate and calcitriol inhibiting bone resorption and regulating calcium homeostasis
Phase 1, Small molecule, VDR, FDPS, osteoporosis

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms3
Trials1
Similar companies6